VSTM: Verastem, Inc. Stock

SIC 2834 – Pharmaceutical Preparations

Valuation
Market Cap ($M) 257.76
Enterprise Value ($M) 245.73
Book Value ($M) 78.53
Book Value / Share 3.10
Price / Book 3.28
NCAV ($M) 72.50
NCAV / Share 2.87
Price / NCAV 3.56

Profitability (mra)
Return on Invested Capital (ROIC) -0.70
Return on Assets (ROA) -0.72
Return on Equity (ROE) -1.61

Liquidity (mrq)
Quick Ratio 5.45
Current Ratio 5.45

Balance Sheet (mrq) ($M)
Current Assets 143.68
Assets 149.72
Liabilities 71.19
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 0.00
Operating Income -92.08
Net Income -87.37
Earnings Per Share Basic And Diluted n/a
Earnings Per Share Diluted n/a
Earnings Per Share Basic n/a

Cash Flow Statement (mra) ($M)
Cash From Operations -86.46
Cash from Investing -44.45
Cash from Financing 134.19

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)
Change
(%)
02-14 13G/A Biotechnology Value Fund L P 9.99
02-14 13G/A Orbimed Advisors Llc 6.10
02-14 13G/A Viking Global Investors Lp 9.99 91.71
02-13 13G/A Vivo Opportunity, LLC 6.10
02-02 13G/A Soleus Capital Master Fund, L.P. 6.80 9.89
08-31 13G Adage Capital Partners Gp, L.l.c. 5.15
08-10 13G/A Baker Bros. Advisors Lp 0.00 -100.00
06-23 13G Flynn James E 6.10 0.00

Top 13F Investors Shares
(1000)
Change
(%)
Value
($1000)
Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

File Date Form SEC Filings
2024-03-14 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-K
2023-11-08 10-Q UNITED STATES
2023-08-08 10-Q UNITED STATES
2023-05-09 10-Q UNITED STATES

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2024-04-18 16,265 21,055 77.25
2024-04-17 6,489 54,337 11.94
2024-04-16 11,076 64,334 17.22
2024-04-15 19,503 117,053 16.66

(click for more detail)

Similar Companies
VIRI – Virios Therapeutics, Inc. VKTX – Viking Therapeutics, Inc.
VRPX – Virpax Pharmaceuticals, Inc. VTGN – Vistagen Therapeutics, Inc.
VTVT – vTv Therapeutics Inc.


Financial data and stock pages provided by
Fintel.io


Finpedia: Verastem